
Sign up to save your podcasts
Or


When a patient does not respond to an SSRI trial, what is the best strategy—increase the dose, augment with another agent, or switch to another SSRI? In this interview, Dr. Hudak discusses dosing strategies and the treatment of patients with OCD and comorbid psychiatric conditions.
Guest: Robert Hudak, M.D. Interviewer: Mohan Gautam, D.O. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.
By Psychopharmacology Institute4.6
269269 ratings
When a patient does not respond to an SSRI trial, what is the best strategy—increase the dose, augment with another agent, or switch to another SSRI? In this interview, Dr. Hudak discusses dosing strategies and the treatment of patients with OCD and comorbid psychiatric conditions.
Guest: Robert Hudak, M.D. Interviewer: Mohan Gautam, D.O. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.

695 Listeners

76 Listeners

495 Listeners

146 Listeners

302 Listeners

3,342 Listeners

161 Listeners

1,353 Listeners

710 Listeners

557 Listeners

472 Listeners

369 Listeners

717 Listeners

191 Listeners

154 Listeners